Copyright
©The Author(s) 2021.
World J Transplant. Mar 18, 2021; 11(3): 70-86
Published online Mar 18, 2021. doi: 10.5500/wjt.v11.i3.70
Published online Mar 18, 2021. doi: 10.5500/wjt.v11.i3.70
Table 4 Summary of biopsy proven acute rejection in clinical trials
| Ref. | IA | IB | IIA | IIB | III | Mixed | ||||||||
| Gp1 (Belatacept) | Gp2 (Tacrolimus) | Gp1 (Belatacept) | Gp2 (Tacrolimus) | Gp1 (Belatacept) | Gp2 (Tacrolimus) | Gp1 (Belatacept) | Gp2 (Tacrolimus) | Gp1 (Belatacept) | Gp2 (Tacrolimus) | Gp1 (Belatacept) | Gp2 (Tacrolimus) | Gp1 (Belatacept) | Gp2 (Tacrolimus) | |
| Ferguson et al[33], 2011 | 0 | 0 | 0 | 0 | 3 | 0 | 2 | 1 | 0 | 0 | ||||
| de Graav et al[34], 2017 | 0 | 0 | 1 | 1 | 2 | 1 | 6 | 0 | 1 | 0 | 1 | 0 | ||
| Newell et al[35], 2017 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | ||
| Clinicaltrial.gov 1856257[36], 2017 | 3 | 0 | 1 | 1 | 4 | 0 | 0 | 0 | 2 | 0 | 1 | 1 | ||
- Citation: Kumar J, Reccia I, Virdis F, Podda M, Sharma AK, Halawa A. Belatacept in renal transplantation in comparison to tacrolimus and molecular understanding of resistance pattern: Meta-analysis and systematic review. World J Transplant 2021; 11(3): 70-86
- URL: https://www.wjgnet.com/2220-3230/full/v11/i3/70.htm
- DOI: https://dx.doi.org/10.5500/wjt.v11.i3.70